Death Cases

Showing of 1 - 20 from 59 results
Death Cases - Total results - 59
Mathematical models use to predict severity of the COVID-19 in India carried elements of bias, assumptions: IJMR
India

Mathematical models use to predict severity of the COVID-19 in India carried elements of bias, assumptions: IJMR

Estimates of modelling studies are "only as good as" the validity of the epidemiological or statistical model used and accuracy of assumptions made for modelling.

COVID-19 may infect the respiratory centre of the brains, nervous system says CSIR researchers
India

COVID-19 may infect the respiratory centre of the brains, nervous system says CSIR researchers

The new research paper implied that coronavirus could enter the human brain through the nose and reach the olfactory bulb of the brain.

Flushing the toilet can fling a cloud of Coronavirus aerosols up to 91 centimetres into the air, infecting another user
science

Flushing the toilet can fling a cloud of Coronavirus aerosols up to 91 centimetres into the air, infecting another user

Growing evidence shows that coronavirus can be passed not only through respiratory droplets but also through virus-laden faeces.

Japanese researchers find presence of COVID-19 in sewage plants, proves to be an early warning signal for transmission
science

Japanese researchers find presence of COVID-19 in sewage plants, proves to be an early warning signal for transmission

Public health experts say such sampling of sewage could be used to estimate the number of infected people in a region without testing every individual.

German biotech company CureVac to launch human trials for an experimental Coronavirus vaccine
science

German biotech company CureVac to launch human trials for an experimental Coronavirus vaccine

The WHO lists 11 experimental coronavirus vaccines is currently being tested on humans, according to a table posted on its website.

FDA rescinds approval for use of hydroxychloroquine for COVID-19 patients, says risks outweighs the benefits
science

FDA rescinds approval for use of hydroxychloroquine for COVID-19 patients, says risks outweighs the benefits

In a separate announcement, the FDA has warned doctors against prescribing the HCQ in combination with remdesivir, the other drug shown to help COVID-19 patients.

Health ministry recommends tocilizumab, HCQ, plasma therapy for patients in the moderate stage of COVID-19
India

Health ministry recommends tocilizumab, HCQ, plasma therapy for patients in the moderate stage of COVID-19

HCQ has demonstrated in-vitro activity against SARS-CoV-2 and shown to be clinically beneficial in several small single-centre studies with significant limitations.

ICMR denies claims that it published a study saying India's coronavirus cases could peak by mid-November
India

ICMR denies claims that it published a study saying India's coronavirus cases could peak by mid-November

The news reports attributing this study to ICMR are misleading. This refers to a non peer reviewed modelling, not carried out by ICMR and does not reflect the official position of ICMR, said the agency

Certain underlying conditions in patients could indicate when a person is more severely affected with COVID-19
science

Certain underlying conditions in patients could indicate when a person is more severely affected with COVID-19

South Korean doctors wrote that diabetes, high body temperature, low oxygen saturation and pre-existing cardiac injury were the prognostic factors for severe COVID-19.

PPE's are effective in preventing Coronavirus infection in healthcare workers that are working in hospitals
science

PPE's are effective in preventing Coronavirus infection in healthcare workers that are working in hospitals

Healthcare professionals working away from home had limited social interactions after work, which probably contributed to the absence of infection.

WHO takes back statement saying asymptomatic patients spreading COVID-19 is rare, says they can cause 40 percent of transmissions
science

WHO takes back statement saying asymptomatic patients spreading COVID-19 is rare, says they can cause 40 percent of transmissions

Maria van Kerkhove said, “Some estimates of around 40 percent of transmission may be due to asymptomatic (cases), but those are from models."

Gilead's Remdesivir prevented lung disease in macaque monkeys infected with coronavirus: Study
science

Gilead's Remdesivir prevented lung disease in macaque monkeys infected with coronavirus: Study

The antiviral drug, Remdesivir is the first drug shown to be effective against COVID-19 in human trials.

Ridiculous: Beijing dismisses Harvard study that suggests COVID-19 was already spreading in China, in August
science

Ridiculous: Beijing dismisses Harvard study that suggests COVID-19 was already spreading in China, in August

The research uses satellite images of hospital parking lots in Wuhan and data for symptom-related queries on search engines for things like “cough” and “diarrhoea”.

Delhi’s COVID-19 infections will climb to more than half a million by July end, state doesn't have the hospital capacity to handle the outbreak
India

Delhi’s COVID-19 infections will climb to more than half a million by July end, state doesn't have the hospital capacity to handle the outbreak

Despite a lockdown since March, the disease is spreading in India, at one of the world’s fastest rates as it re-opens a battered economy.

China defends its Coronavirus efforts in an 84 page report, says they 'wasted no time' in sharing information
science

China defends its Coronavirus efforts in an 84 page report, says they 'wasted no time' in sharing information

National Health Commission Chairman Ma Xiaowei said they "made an important contribution to the prevention and control of the epidemic around the world.”

Vaccine for all: UK Lab aims to sidestep expensive drug industry to sell its potential COVID-19 vaccine at a cheaper rate
science

Vaccine for all: UK Lab aims to sidestep expensive drug industry to sell its potential COVID-19 vaccine at a cheaper rate

The vaccine’s lower cost could appeal to large donor organizations that supply low-income countries and provide a cheaper alternative in affluent countries.

The jury is still out on Hydroxychloroquine after the global debacle have left scientists uncertain of its usage
science

The jury is still out on Hydroxychloroquine after the global debacle have left scientists uncertain of its usage

The WHO paused its trials when The Lancet study showed the drug was tied to an increased risk of death in hospitalized patients.

Authors retract Lancet study that claimed higher death risk for COVID-19 patients treated with hydroxychloroquine
India

Authors retract Lancet study that claimed higher death risk for COVID-19 patients treated with hydroxychloroquine

An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients was retracted on Thursday, adding to controversy around a drug championed by US President Donald Trump.

WHO will resume its trial of hydroxychloroquine after studies claiming increased death rates are called into question
World

WHO will resume its trial of hydroxychloroquine after studies claiming increased death rates are called into question

WHO’s chief scientist said “We owe it to patients to have a definitive answer on whether or not a drug works."

Doctors will test ibuprofen to see if it reduces respiratory failure in patients with severe COVID-19 symptoms
science

Doctors will test ibuprofen to see if it reduces respiratory failure in patients with severe COVID-19 symptoms

The trial, known as "LIBERATE", will be a randomised study, with the recruitment of up to 230 patients expected over the coming months.